(0.03%) 5 297.00 points
(-0.09%) 38 755 points
(0.24%) 18 636 points
(0.18%) $77.13
(4.02%) $2.69
(0.03%) $2 346.40
(-0.26%) $30.36
(-0.46%) $1 037.20
(0.16%) $0.923
(0.08%) $10.49
(0.21%) $0.787
(-1.06%) $89.48
3 days till quarter result
(tns 2024-06-06)
Expected move: +/- 7.40%
@ $0.910
Issued: 13 Feb 2024 @ 14:52
Return: -35.16%
Previous signal: Feb 12 - 13:31
Previous signal:
Return: 3.99 %
Live Chart Being Loaded With Signals
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States...
Stats | |
---|---|
Today's Volume | 861 419 |
Average Volume | 1.62M |
Market Cap | 133.47M |
EPS | $0 ( 2024-05-14 ) |
Next earnings date | ( $-0.190 ) 2024-06-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.690 |
ATR14 | $0.00100 (0.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-27 | Christian Waage | Sell | 6 430 | Common Stock |
2024-03-27 | Giraudo Bryan | Sell | 6 430 | Common Stock |
2024-03-27 | Hasnain Faheem | Sell | 23 172 | Common Stock |
2024-03-18 | Aranda Richard | Sell | 4 018 | Common Stock |
2024-03-18 | Peterson Caryn | Sell | 4 018 | Common Stock |
INSIDER POWER |
---|
76.60 |
Last 96 transactions |
Buy: 11 435 031 | Sell: 1 983 654 |
Volume Correlation
Gossamer Bio Inc Correlation
10 Most Positive Correlations | |
---|---|
CRSP | 0.944 |
BEAM | 0.929 |
FONR | 0.913 |
ASO | 0.9 |
GRPN | 0.893 |
CSX | 0.885 |
NUVL | 0.884 |
ULTA | 0.877 |
TERN | 0.872 |
NWS | 0.869 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Gossamer Bio Inc Correlation - Currency/Commodity
Gossamer Bio Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-4.39M (0.00 %) |
EPS: | $-1.180 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-4.39M (0.00 %) |
EPS: | $-1.180 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-4.43M (0.00 %) |
EPS: | $-2.84 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-3.13 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Gossamer Bio Inc
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators